The weekly litigation news digest is live. Subscribe now

IP Verse

Patent Oppositions in infection drugs industry

Explore the competitive field of infection drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in infection drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for infection drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Nov 20, 2025
CompanyTotal Oppositions
SANDOZ9
GENERICS UK8
STRAWMAN8
TEVA PHARMACEUTICALS8
NUTRICIA7
BOEHRINGER INGELHEIM7
HAMM & WITTKOPP6
COOKE6
NESTLE5
FRESENIUS KABI DEUTSCHLAND5

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Nov 20, 2025
CompanyTotal Oppositions
GILEAD SCIENCES19
VIIV HEALTHCARE18
NUTRICIA10
MERCK SHARP & DOHME9
GLAXOSMITHKLINE9
NESTLE7
NESTEC7
PFIZER6
INTERVET6
ESTEVE QUMICA6

Top active law firms filing patent oppositions

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Nov 20, 2025
Law FirmTotal Oppositions Filed
ELKINGTON AND FIFE18
D YOUNG16
TER MEER STEINMEISTER & PARTNER15
CARPMAELS & RANSFORD11
HAMM & WITTKOPP10
HOFFMANN EITLE8
NEDERLANDSCH OCTROOIBUREAU7
KRAUS & LEDERER PARTGMBB6
MEWBURN ELLIS6
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB6

Latest patents opposed in the infection drugs industry

Patent challenges are becoming increasingly common in the infection drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the infection drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
EP3824905
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER RESEARCH CENTEROct 8, 2025BOULT WADE TENNANT
EP3609579
Antimicrobial Compounds From The Genus DelftiaTEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICESOct 1, 2025SCORPIO
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECASep 17, 2025GENERICS UK
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 4, 2025ELKINGTON AND FIFE
EP4233846
Pharmaceutical FormulationsGILEAD SCIENCESSep 4, 2025ELKINGTON AND FIFE
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
EP4233846
Pharmaceutical FormulationsGILEAD SCIENCESSep 3, 2025EIP
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
EP4233846
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
EP4349333
Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated FatigueBHMEKEJul 29, 2025LANGE

Top patents facing oppositions in infection drugs industry

To stay ahead in the competitive infection drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the infection drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
EP3494972
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE10
EP2899193
Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA6
EP3597216
Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS5
EP3321270
Dec 4, 2024Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCES5
EP4008357
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE4
EP3127542
Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE4
EP3391890
Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-CyclodextrinMERCK SHARP & DOHME4
EP2943192
Sep 29, 2021Methods Of Treating Pancreatic CancerABRAXIS BIOSCIENCE4
EP3153526
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
EP2682397
Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3